By Kathleen Doheny
HealthDay Reporter
WEDNESDAY, July 27 (HealthDay News) — The widely used mammography software known as computer-aided detection (CAD) doesn’t improve detection of invasive breast cancer, new research suggests.
But CAD does increase the chances that a woman will be called back for further testing, according to the study, published July 27 in the Journal of the National Cancer Institute.
By Maureen Salamon
HealthDay Reporter
TUESDAY, July 26 (HealthDay News) — A lymph node-sparing test hailed as revolutionary for its conservative approach does not lead to longer survival times for women undergoing lumpectomies whose early-stage breast cancer has spread microscopically, a large, new study suggests.
Examining the medical records of more than 5,200 patients who underwent breast-conserving surgery for early, invasive breast cancer, researchers found that tiny cancer cells in the sentinel lymph node — the first node to which malignant cells are likely to spread from a primary tumor — detected with a diagnostic procedure called immunohistochemical (IHC) staining had no effect on overall survival.
MONDAY, July 25 (HealthDay News) — Many doctors are not following guidelines on genetic counseling and testing for women at average and high risk for breast and ovarian cancer, according to a new study.
This lack of compliance could result in women missing out on treatments that could reduce their chances of developing these diseases, the researchers pointed out in a report published in the July 25 online edition of the journal Cancer.
By Maureen Salamon
HealthDay Reporter
WEDNESDAY, July 20 (HealthDay News) — The value of annual mammograms for women in their 40s — the topic of a lingering debate among health policy and advocacy groups — has drawn resounding support from the nation’s largest group of obstetricians/gynecologists.
On Wednesday, the American College of Obstetricians and Gynecologists (ACOG) issued new guidelines calling for mammograms to be done every year beginning at age 40. This is a departure from its previous recommendations, which advised mammograms every one to two years beginning at 40 and then annually beginning at age 50, based on the incidence of breast cancer in younger women and its typically more rapid progression, guidelines co-author Dr. Jennifer Griffin explained.
By Amanda Gardner
HealthDay Reporter
TUESDAY, July 19 (HealthDay News) — Giving the ovaries a rest when young women with breast cancer are undergoing chemotherapy may help prevent early menopause and preserve fertility.
According to new research in the July 20 issue of the Journal of the American Medical Association, shutting down the ovaries by giving the hormone triptorelin when a patient is undergoing chemotherapy helped prevent early menopause.
TUESDAY, July 12 (HealthDay News) — The immune systems of people with contact allergies may be primed to protect against certain types of cancer, including breast and brain cancers, new research suggests.
Contact allergies occur due to direct contact with chemicals and common metals such as nickel.
Read More
WEDNESDAY, July 6 (HealthDay News) — An estimated 20 percent of breast cancer patients in the United States who receive radiation after they undergo breast-conserving surgery may not have their radiation treatments recorded in a federal database, a new study suggests.
The Surveillance Epidemiology and End Results (SEER) registry is maintained by the U.S. National Cancer Institute and is used by researchers to examine patterns of cancer treatment, including racial or regional disparities.
By Ellin Holohan
HealthDay Reporter
WEDNESDAY, July 6 (HealthDay News) — Hopes that breast-feeding can reduce flare-ups of multiple sclerosis have been dimmed by recent research in Italy.
Researchers at the University of Florence found no support for prior studies connecting breast-feeding with lower disease activity for women with the degenerative nerve disorder commonly known as MS.
By Kathleen Doheny
HealthDay Reporter
TUESDAY, July 5 (HealthDay News) — The timing and frequency of mammography to detect breast cancer is a decision best customized for each woman, based on such factors as age and breast density, new research suggests.
One schedule for all women based on age alone is not the best approach, said study lead author Dr. John Schousboe, medical director of research at Park Nicollet Health Services in Minneapolis and adjunct professor of health policy and management at the University of Minnesota.
By Steven Reinberg
HealthDay Reporter
FRIDAY, July 1 (HealthDay News) — Oncologists and even some breast cancer support groups are endorsing a U.S. health advisory panel’s recommendation that the blockbuster cancer drug Avastin be removed for use in metastatic breast cancer.
The reason: There’s still a lack of understanding of how the drug works or who it helps.
| Text Size: |  |
|
